Edward A. Ogunro
Directeur/Membre du Conseil chez MPN Research Foundation
Profil
Edward A.
Ogunro is currently a Director at MPN Research Foundation, DelNova, Inc., and Prenosis, Inc. He was previously the Lead Independent Director at Luminex Corp.
from 2020 to 2021, a Director at Applied NeuroSolutions, Inc. from 2008 to 2011, the Chief Scientific Officer & Senior VP-Research at Hospira, Inc. from 2004 to 2007, and an Assistant Professor at Feinberg School of Medicine from 1977 to 1982.
He also held positions at Abbott Laboratories and Abbott Hospital Products.
Ogunro holds a doctorate from the University of London and an undergraduate degree from The University of Reading.
Postes actifs de Edward A. Ogunro
| Sociétés | Poste | Début |
|---|---|---|
| MPN Research Foundation | Directeur/Membre du Conseil | - |
DelNova, Inc.
 DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | Directeur/Membre du Conseil | - |
Prenosis, Inc.
 Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Directeur/Membre du Conseil | 05/10/2022 |
Anciens postes connus de Edward A. Ogunro
| Sociétés | Poste | Fin |
|---|---|---|
| LUMINEX CORPORATION | Directeur/Membre du Conseil | 14/07/2021 |
Applied NeuroSolutions, Inc.
 Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Directeur/Membre du Conseil | 19/01/2011 |
| HOSPIRA, INC. | Directeur Technique/Scientifique/R&D | 01/12/2007 |
| Feinberg School of Medicine | Corporate Officer/Principal | 01/01/1982 |
| Abbott Hospital Products | Conseiller Juridique Général | - |
Formation de Edward A. Ogunro
| University of London | Doctorate Degree |
| The University of Reading | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 7 |
|---|---|
Luminex Corp.
 Luminex Corp. Medical SpecialtiesHealth Technology Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Health Technology |
| Abbott Hospital Products | |
| MPN Research Foundation | |
DelNova, Inc.
DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | Health Technology |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Technology Services |
